常咯啉在实验性心律失常狗的药代动力学-药效动力学分析

用Harris冠脉结扎法诱发的心律失常狗研究常咯啉药代动力学-药效动力学。7只狗按83.33μg·kg^-1·min^-1静脉滴注60min,在给药期间和停药后不同时间记录ECG及测定血药浓度。C-T数据用药代程序计算药代参数;药效数据用药代-药效同步分析模型计算药效动力学参数,K₁₀, T_1/2,Vd,Cl分别为0.0087min^-1,78.03min,40.55ml·kg^-1和0.421ml·kg^-1·min^-1;K_eO和Ce(50)分别为0.0048min^-1和2.01μg·ml^-1.     

6－甲氧基正丁苯酞的体内代谢转化研究

大鼠用６－甲氧基正丁苯酞（ＭＢＰ）灌胃，收集０～２４ｈ尿液，经酶水解、提取浓缩、衍生化处理后用ＧＣ／ＭＳ分析。在大鼠０～２４ｈ尿液中，６－甲氧基正丁苯酞原药含量很低，主要以代谢物形式存在，依次为Ｃ－６脱甲基产物、Ｃ３－Ｃα环氧化物、γ－羟化物、β－羟化物以及两个次级代谢产物。６－甲氧基正丁苯酞体内代谢结果与其在肝微粒体中代谢结果基本一致。     

Outcome of Pregnancy in an Oxford-Cardiff Cohort of Women with Previous Bacteriuria

To investigate the influence of asymptomatic bacteriuria inchildhood on subsequent pregnancy, we reviewed the outcome of139 pregnancies in 88 women who were first identified duringa programme of screening schoolgirls for asymptomatic bacteriuriacarried out between 1970–1972 [1]. Data were analysedfor the following groups: 50 pregnancies in 28 women with knownrenal scars (group 1); 16 pregnancies in 14 women with normalkidneys and reflux (group 2); 73 pregnancies in 46 women withnormal urinary tracts (group 3); 139 healthy controls. Women in group 1 had a 3.3-fold increased relative risk of hypertension(p < 0.01) and a 7.6-fold increased risk of pre-eclampsia(p< 0.05) compared to controls, and a higher rate of obstetricinterventions, including emergency caesarean section. Womenin groups 2 and 3 appeared to carry a slightly increased riskof hypertension during the last trimester (RR = 1.8) but therewere no significant differences in this or the incidence ofpre-eclampsia or mode of delivery. Bacteriuria was more prevalentin all index groups compared to controls (37 per cent vs. 8per cent, p < 0.01) and included four cases of acute pyelonephritisin the study group. Fetal outcome was satisfactory in all cases.These results suggest that women with renal scars are at riskof hypertension and pre-eclampsia during pregnancy but thatmodern obstetric care minimizes these risks.     

In-111-labeled white blood cell uptake in noninfected closed fracture in humans: prospective study

Since indium-111 white blood cell (In-111 WBC) scintigraphy is often used to evaluate for osteomyelitis in bone fractures, it is important to know if noninfected fractures have In-111 WBC uptake. Twenty-seven noninfected closed fracture sites in 19 patients were prospectively evaluated with technetium-99m methylene diphosphonate bone scintigraphy and In-111 WBC scintigraphy. In-111 WBC uptake was present in 41% of the 27 sites. In the 11 positive sites, the In-111 WBC uptake was 1+ (definite but minimal) in 55%, 2+ (moderate) in 36%, and 3+ (marked) in 9%. The visual intensity of the radioactive uptake on In-111 WBC scintigrams relative to that on bone scintigrams was less in 82%, equal in 9%, and greater in 9%. The visual size of the area of uptake on In-111 WBC scintigrams and bone scintigrams was smaller in 36%, equal in 55%, and greater in 9%. Factors that may help distinction of In-111 WBC uptake due to fracture alone from infection associated with fracture are discussed.     

Epidemiologic background and long-term course of disease in human immunodeficiency virus type 1-infected blood donors identified before routine laboratory screening. Transfusion Safety Study Group

BACKGROUND: The long-term course of human immunodeficiency virus type 1 (HIV-1)-related disease among seropositive blood donors has not been described. The enrollment and epidemiologic background of HIV-1- infected donors in the Transfusion Safety Study and their immunologic and clinical progression are described. STUDY DESIGN AND METHODS: Through the testing of approximately 200,000 sera from donations made in late 1984 and early 1985, 146 anti-HIV-1-positive donors and 151 uninfected matched donors were enrolled. These two cohorts were followed with 6-month interval histories and laboratory testing. RESULTS: Seropositive donors detected before the institution of routine anti-HIV-1 screening disproportionately were first-time donors and men with exclusively male sexual contacts. The actuarial probability of a person's developing AIDS within 7 years after donation was 40 percent; the probability of a person's dying of AIDS was 28 percent. AIDS developed more often when the donor was p24 antigen-positive at donation. Over a 3-year period, significant decreases occurred in CD4+, CD2+CD26+, CD4+CD29+, and CD20+CD21+ counts, but not in CD8+ subsets, CD20+, or CD14+. CONCLUSION: The high proportions of first-time donations and exclusively homosexual men among seropositive donors suggest that test-seeking may have contributed to the high HIV-1 prevalence in the repository. Implementation of alternative test sites when routine donor screening began in 1985 may have averted many high- risk donations. The disease course in HIV-1-infected donors had the same wide spectrum of immunologic and clinical manifestations as were reported for other cohorts.